Clinical Trials Logo

Chronic Kidney Diseases clinical trials

View clinical trials related to Chronic Kidney Diseases.

Filter by:

NCT ID: NCT05913362 Not yet recruiting - Clinical trials for Coronary Artery Disease

IVUS Guided PCI for CKD to Reduce CI-AKI

IVUS-CKD
Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Patients with Chronic kidney disease are most vulnerable to contrast induced nephropathy after Percutaneous coronary intervention, intravascular ultrasound guidance can be used to safely guide the procedure to reduce the contrast usage, this randomized trial is design to test the hypothesis that IVUS based ultra-low contrast PCI is feasible and can reduce the contrast induced nephropathy.

NCT ID: NCT05819320 Not yet recruiting - Clinical trials for Chronic Kidney Diseases

Mucocutaneous Manifestations in Patients With Chronic Kidney Disease inNewVally and Assuit;Hospital Based Study

Start date: June 2024
Phase:
Study type: Observational [Patient Registry]

1. To study the patterns of mucocutaneous disorders in Chronic Kidney Disease patients in Eldakhla General Hospital, New Valley and in Assiut University hospital . 2. Comparison of the patterns of mucocutaneous manifestations and their correlation with the different stages of Chronic Kidney Disease in renal unit of internal medicine of Eldakhla general hospital in New Vally and pediatric and adult renal units of Assuit university hospital .

NCT ID: NCT05793346 Not yet recruiting - Pregnancy Related Clinical Trials

Pregnancy-associated Progression of Chronic Kidney Disease: A Study Protocol for the Development and Validation of a Clinical Predictive Tool

PREDICT
Start date: March 2023
Phase:
Study type: Observational

To develop and validate a tool that estimates the degree of pregnancy-associated progression of renal disease in women with CKD and pregnancy outcomes in an international multicentre cohort study.

NCT ID: NCT05734989 Not yet recruiting - Type 2 Diabetes Clinical Trials

Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD

Start date: April 2024
Phase:
Study type: Observational

In this study, the investigators will utilize community organizations to screen Hispanics/Latino(a)s for kidney disease, diabetes, and other risk factors, and refer them for care with a PCP. Additionally, the investigators will implement an intervention in local health clinics to assist PCPs with screening and treating patients with diabetes. Completion of the project will hopefully slow progression of kidney disease among Hispanic/Latino(a) patients in Durham, and the information gained will allow the investigators to eventually perform the intervention on a larger scale.

NCT ID: NCT05696028 Not yet recruiting - Clinical trials for Chronic Kidney Diseases

Comparison of Different Gfr Measurements in Chronic Kidney Diseases

Start date: February 1, 2023
Phase:
Study type: Observational

Comparison of different Gfr measurements in Chronic Kidney Diseases

NCT ID: NCT05691257 Not yet recruiting - Heart Failure Clinical Trials

Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia

Start date: February 1, 2023
Phase: Phase 4
Study type: Interventional

The purpose of this study is to conduct a a cohort study to evaluate the efficacy and safety of the efficacy and safety of roxadustat for the treatment of anemia, quality of life and cardiac function in patients with heart failure and chronic kidney disease.

NCT ID: NCT05675202 Not yet recruiting - Clinical trials for Chronic Kidney Diseases

Material Balance Study of TQ-B3525

Start date: January 2023
Phase: Phase 1
Study type: Interventional

A clinical study to investigate the absorption, metabolism and excretion of [14C] TQ-B3525 in Chinese adult male healthy subjects, aiming to quantitatively analyze the total radioactivity in the excreta of male healthy subjects after oral administration of [14C] TQ-B3525, obtain the data of human radioactive excretion rate and main drainage routes, investigate the distribution in whole blood and plasma, the distribution in plasma and the pharmacokinetics of total radioactivity in plasma, and identify the main metabolites, To determine the main biotransformation pathway and obtain the pharmacokinetic parameters of TQ-B3525 and its metabolites in plasma.

NCT ID: NCT05657236 Not yet recruiting - Clinical trials for Chronic Kidney Diseases

Effect of Strength and Conditioning Training on Functional Performance in Children With Chronic Kidney Disease

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

Despite the benefits of physical rehabilitation among adults and children with chronic illness, they avoid to engage in different physical activities especially pediatric population. Most of the children with Chronic kidney disease receive their medical treatment and follow-up with no change of their functional performance. We still lack the evidence of plyometric exercises in pediatric population with Chronic kidney disease . Therefore, the primary aim of this study is to explore the effects of strength and conditioning training in the form of plyometric exercises on balance and muscle strength in children with Chronic kidney disease .

NCT ID: NCT05655325 Not yet recruiting - Clinical trials for Mild Cognitive Impairment

Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

EXEC
Start date: February 29, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to see if 6 months of home-based walking will improve memory, and brain structure and function, compared to health education in older adults that have chronic kidney disease and mild cognitive impairment.

NCT ID: NCT05473325 Not yet recruiting - Obesity Clinical Trials

Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)

BRANCH-P
Start date: January 1, 2023
Phase:
Study type: Observational

This research programme seeks to combine the resources of NHS primary care, with the leading spectroscopic work in low-magnetic fields of the Wilson Group (Nottingham Trent University) to demonstrate the potential for benchtop Nuclear Magnetic Resonance (NMR) spectroscopy in human clinical pathology. This is an instrument assessment study for point of care viability which will also result in enhanced patient care (pending their consent) in blood screenings and metabolic health data.